Onxeo S.A.: Onxeo: Combined General Meeting of June 6, 2023: Availability of Preparatory Documents and Participation & Voting Procedures

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage Response (DDR) and

Related Keywords

Paris ,France General ,France ,Onxeo Sa Euronext ,Onis Onxeo ,Arthur Rouill ,Nicolas Fossiez ,Gewinn Nur ,Raymond Poincar ,Renaissance Paris Nobel Tour Eiffel Hotel ,Company Group ,Regulatory News ,Euronext Growth Paris ,Combined General Meeting ,General Meeting ,General Meetings ,Investor Relations ,Onxeo ,Combined ,Eneral ,Meeting ,Pune ,023 ,Availability ,Preparatory ,Documents ,Participation ,Voting ,Procedures ,